Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Phillip G Durham"'
Autor:
Stephanie A Montgomery, Ellen F Young, Phillip G Durham, Katelyn E Zulauf, Laura Rank, Brittany K Miller, Jennifer D Hayden, Feng-Chang Lin, John T Welch, Anthony J Hickey, Miriam Braunstein
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204495 (2018)
New therapeutic strategies are needed to treat drug resistant tuberculosis (TB) and to improve treatment for drug sensitive TB. Pyrazinamide (PZA) is a critical component of current first-line TB therapy. However, the rise in PZA-resistant TB cases j
Externí odkaz:
https://doaj.org/article/54319f93be4845eab70a517b83e13e36
Autor:
Phillip G. Durham, Ashelyn E. Sidders, Jenna E. Beam, Katarzyna M. Kedziora, Paul A. Dayton, Brian P. Conlon, Virginie Papadopoulou, Sarah E. Rowe
Publikováno v:
Biofilm, Vol 3, Iss , Pp 100049- (2021)
Bacterial biofilms, often associated with chronic infections, respond poorly to antibiotic therapy and frequently require surgical intervention. Biofilms harbor persister cells, metabolically indolent cells, which are tolerant to most conventional an
Externí odkaz:
https://doaj.org/article/ed9cc9a73dc4482bb59e56b77037462b
Publikováno v:
Ultrasound in Medicine & Biology. 49:1679-1685
Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment
Autor:
Ian E. Stewart, Phillip G. Durham, Jacob M. Sittenauer, Aranza P. Barreda, Grayson W. Stowell, Carmella Moody, Jeffery B. Mecham, Catherine Simpson, Sharon Daily, Sara E. Maloney, Mark D. Williams, Diana Severynse-Stevens, Anthony J. Hickey
Publikováno v:
Pharmaceutical Research. 39:3359-3370
Tuberculosis (TB) remains one of the most serious diseases caused by a single organism. Multiple (MDR) and extensively (XDR) drug resistant disease poses a threat to global health and requires new drugs and/or innovative approaches to treatment. A nu
Autor:
Phillip G. Durham, Awaneesh Upadhyay, J. Angel Navarro-Becerra, Richard E. Moon, Mark A. Borden, Paul A. Dayton, Virginie Papadopoulou
Publikováno v:
Ultrasound in Medicine & Biology.
Publikováno v:
Ultrasound Med Biol
Phase-change contrast agents (PCCAs) consisting of lipid-encapsulated low-boiling point perfluorocarbons can be used in conjunction with ultrasound for diagnostic and therapeutic applications. One benefit of PCCAs is site-specific activation, whereby
Autor:
Christian T. McHugh, Phillip G. Durham, Sebastian Atalla, Michele Kelley, Nicholas J. Bryden, Paul A. Dayton, Rosa T. Branca
Publikováno v:
ChemPhysChem. 23
Publikováno v:
2022 IEEE International Ultrasonics Symposium (IUS).
Autor:
Christian T. McHugh, Phillip G. Durham, Sebastian Atalla, Michele Kelley, Nicholas J. Bryden, Paul A. Dayton, Rosa T. Branca
Publikováno v:
Chemphyschem : a European journal of chemical physics and physical chemistry. 23(24)
Detection of bare gas microbubbles by magnetic resonance (MR) at low concentrations typically used in clinical contrast-ultrasound studies was recently demonstrated using hyperCEST. Despite the enhanced sensitivity achieved with hyperCEST, in vivo tr
Autor:
Virginie Papadopoulou, Ashelyn E. Sidders, Kuan-Yi Lu, Amanda Z. Velez, Phillip G. Durham, Duyen T. Bui, Michelle Angeles-Solano, Paul A. Dayton, Sarah E. Rowe
Publikováno v:
Cell Chemical Biology. 30:513-526.e5